GlassScriptPhysician profile
Andres Elovic
NPI 1417539420
$1,684.87
in general payments reported to CMS, 2019-2025
13 companies · $931 in 2025
The $931 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $55.66 · 2023: $360 · 2024: $215 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $373.15 | 2023-2024 | Spaceoar Vue System - 10ml, Ams 700, Ams 700 Cxr Rte Kit |
| Pfizer INC. | $252.37 | 2022-2025 | |
| Valencia Technologies Corporation | $194.71 | 2025 | Ecoin Device Kit |
| Olympus America INC. | $157.80 | 2025 | Gyrus Acmi, Soltive, Itind System |
| Immunitybio, INC. | $146.32 | 2025 | |
| Novo Nordisk INC | $134.78 | 2025 | |
| Urogen Pharma, INC. | $88.37 | 2023-2025 | Jelmyto |
| Janssen Biotech, INC. | $87.54 | 2025 | Rybrevant, Carvykti, Erleada |
| Progenics Pharmaceuticals, INC. | $47.55 | 2025 | |
| Biotissue Holdings INC. | $27.90 | 2023 | |
| Novartis Pharmaceuticals Corporation | $21.06 | 2024 | |
| Abbvie INC. | $15.73 | 2025 | |
| Philips North America LLC | $13.98 | 2024 | (8584) Uronav |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Elovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.